Fig. 4From: First preclinical evaluation of [225Ac]Ac-DOTA-JR11 and comparison with [177Lu]Lu-DOTA-JR11, alpha versus beta radionuclide therapy of NETsComparison of A tumor, B kidneys, C liver and D bone TAC of [225Ac]Ac-DOTA-JR11 (blue curves) and [177Lu]Lu-DOTA-JR11 (brown curves). Single-exponential curve fits are shown with 95% confidence intervalsBack to article page